Showing 1 posts of 1 posts found.
EVerZom, a French biotech company developing exosome-based therapies for regenerative medicine, has entered into a research and licensing agreement with …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO